GenMont Biotech Incorporation (TPE:3164)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.05
+0.10 (0.56%)
Apr 20, 2026, 1:23 PM CST

TPE:3164 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,5441,5781,7482,1372,0472,103
Market Cap Growth
-17.76%-9.68%-18.22%4.39%-2.67%9.23%
Enterprise Value
1,4081,4811,7062,0221,8181,937
Last Close Price
17.9517.5618.6422.3320.8520.48
PE Ratio
27.2027.5930.5264.7735.9318.59
PS Ratio
3.853.934.546.725.554.92
PB Ratio
1.061.091.181.481.371.38
P/TBV Ratio
1.161.191.301.631.521.53
P/FCF Ratio
22.0022.4921.871655.1831.11-
P/OCF Ratio
20.9821.4514.1061.7614.9418.84
EV/Sales Ratio
3.513.694.436.364.934.53
EV/EBITDA Ratio
11.3212.2915.7729.3916.5413.54
EV/EBIT Ratio
24.3825.6541.98289.2929.3415.49
EV/FCF Ratio
20.0621.1021.351565.8627.64-
Debt / Equity Ratio
0.080.080.080.040.020.02
Debt / EBITDA Ratio
0.890.891.060.810.310.22
Debt / FCF Ratio
1.571.571.4945.160.53-
Net Debt / Equity Ratio
-0.18-0.18-0.16-0.19-0.24-0.25
Net Debt / EBITDA Ratio
-2.12-2.12-2.22-3.93-3.33-2.72
Net Debt / FCF Ratio
-3.63-3.63-3.00-209.14-5.5773.63
Asset Turnover
0.240.240.230.190.220.26
Inventory Turnover
2.022.021.781.492.423.58
Quick Ratio
3.183.182.802.522.823.43
Current Ratio
4.284.283.873.183.244.17
Return on Equity (ROE)
3.28%3.28%3.26%1.52%3.14%7.29%
Return on Assets (ROA)
2.14%2.14%1.51%0.26%2.28%4.72%
Return on Invested Capital (ROIC)
3.66%3.57%2.48%0.48%3.92%8.99%
Return on Capital Employed (ROCE)
3.80%3.80%2.60%0.50%4.00%8.00%
Earnings Yield
3.70%3.62%3.28%1.54%2.78%5.38%
FCF Yield
4.55%4.45%4.57%0.06%3.21%-0.25%
Dividend Yield
4.46%4.56%4.29%2.24%3.36%5.37%
Payout Ratio
121.00%121.00%75.56%183.26%166.75%53.42%
Buyback Yield / Dilution
0.23%0.23%-0.18%0.10%0.09%1.50%
Total Shareholder Return
4.69%4.79%4.11%2.34%3.45%6.87%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.